CDC Advisers Weigh Ramifications As They Punt Vote On J&J Vaccine Pause

By Beth Wang / April 14, 2021 at 7:17 PM
FDA and the Centers for Disease Control and Prevention’s pause on use of Johnson & Johnson’s COVID-19 vaccine remains in effect after CDC’s vaccine advisory committee on Wednesday (April 14) temporarily put off any interim recommendations or a vote for or against the pause until more information on the rare blood clots linked to the vaccine are available. Committee members weighed what additional data are needed, whether FDA should add statements to patient and provider fact sheets, and how the...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.